Close Menu
Invest Insider News
    Facebook X (Twitter) Instagram
    Tuesday, November 17
    Facebook X (Twitter) Instagram Pinterest Vimeo
    Invest Insider News
    • Home
    • Bitcoin
    • Commodities
    • Finance
    • Investing
    • Property
    • Stock Market
    • Utilities
    Invest Insider News
    Home»Investing»Telix Pharmaceuticals stock rises after European regulatory submission By Investing.com
    Investing

    Telix Pharmaceuticals stock rises after European regulatory submission By Investing.com

    February 17, 20262 Mins Read


    Investing.com — stock rose 1.9% in after-hours trading Tuesday following the company’s announcement of a marketing authorization application (MAA) submission in Europe for its brain cancer imaging agent.

    The Australian-based radiopharmaceutical company is seeking approval for TLX101-Px, a positron emission tomography (PET) imaging candidate designed to distinguish progressive or recurrent glioma from treatment-related changes in both adult and pediatric patients. The submission covers major European markets and aims to expand patient access to advanced brain imaging through a broad clinical label that reflects current clinical practice guidelines.

    Currently in Europe, PET imaging of glioma with 18F-FET (the active component of TLX101-Px) is performed under physician-supervised use through hospital-based production at limited sites. Telix aims to address the lack of a generally available commercial product that ensures consistent quality and access.

    “We see a compelling opportunity in Europe to broaden access to authorized targeted radiopharmaceuticals for brain cancer imaging and therapy, and as such this submission is an important milestone for Telix,” said Kevin Richardson, Chief Executive Officer of Telix Precision Medicine.

    The company has been preparing regulatory packages for both European and U.S. markets concurrently, bringing forward the European submission while aligning with aspects of the U.S. Food and Drug Administration package. Telix plans to follow with a New Drug Application submission in the United States.

    TLX101-Px is also being developed as a patient selection and response assessment tool for Telix’s glioblastoma therapy candidate TLX101-Tx, which has received orphan drug designation in both Europe and the U.S. and is the subject of the Phase 3 IPAX-BrIGHT trial in patients with recurrent glioblastoma.

    This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.





    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleStock Market Today, Feb. 17: Norwegian Cruise Line Jumps After Elliott Reveals 10% Stake and Activist Campaign
    Next Article Utilities Down, But Not by Much, Amid Deal Activity — Utilities Roundup

    Related Posts

    Investing

    NZD/INR Historical Data | New Zealand Dollar Indian Rupee

    October 30, 2026
    Investing

    GBP 2 Years IRS Interest Rate Swap Bond Chart (Live Data)

    October 27, 2026
    Investing

    USD/CNY Historical Data | US Dollar Chinese Yuan

    October 25, 2026
    Leave A Reply Cancel Reply

    Top Posts

    How is the UK Commercial Property Market Performing?

    December 31, 2000

    How much are they in different states across the US?

    December 31, 2000

    A Guide To Becoming A Property Developer

    December 31, 2000
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews
    Commodities

    Indonesia’s Prabowo Subianto retreats on commodities reform amid market pressure

    August 13, 2026
    Bitcoin

    Hut 8 Secures $200M Bitcoin-Backed Credit Facility from FalconX

    May 4, 2026
    Bitcoin

    BTC upgrade against quantum computing threat might take years

    December 22, 2025
    What's Hot

    ‘Soon, all commodity charts will look like gold.’ BofA’s Hartnett goes bullish on commodities.

    December 5, 2025

    Spot bitcoin ETFs get SEC approval for options trading

    October 21, 2024

    Metaplanet Expands Bitcoin Strategy with New Venture Firm

    March 13, 2026
    Most Popular

    Trump Card Turns Markets on a Dime as Stocks, Bonds Stage Substantial Recovery

    March 23, 2026

    Bitcoin Prix Trend supérieur à 100 000 $: la bonne nouvelle et la mauvaise nouvelle

    June 1, 2025

    Utility rate increase in Fargo proposed for 2025 – InForum

    July 12, 2024
    Editor's Picks

    UK property transactions stabilise in June after declines

    August 2, 2026

    L’État du Sénégal mandate Invictus Capital Finance et lève 150 milliards de FCFA

    March 28, 2025

    These are the best US cities to call home

    August 20, 2025
    Facebook X (Twitter) Instagram Pinterest Vimeo
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions
    © 2026 Invest Insider News

    Type above and press Enter to search. Press Esc to cancel.